Updating monitoring strategies and combining them with the latest technology can streamline clinical trial processes to generate higher quality data and increase patient safety, says Brett Wilson.

Safety monitoring in clinical trials is ... the goal of ensuring participant safety in clinical trials. Aggregate Safety Assessment Plan (ASAP): A structured framework for collecting and analyzing ...

She has led PRIDE, one of IQVIA’s largest employee resource groups, and is dedicated to increasing sustainable clinical trial monitoring models for the industry’s future.

Correspondence to Dr Thomas Bandholm, Dept of Clinical Research ... approach will help you report important trial items in the same order and with the same wording as used in the registration.

A clinical trial is one that involves human participants and seeks to answer specific questions about a type of medical intervention. This can be a drug or other type of treatment, such as nutritional ...

Objective To develop recommendations on monitoring for adverse events (AEs) of low-dose glucocorticoid (GC) therapy (≤7.5 mg prednisone or equivalent daily) in clinical trials and daily practice.

The ALIVE clinical ... This allowed the trial to proceed to Phase III, where efficacy was assessed in a much larger number of participants, alongside continued safety monitoring.

Recent trials have demonstrated limited correlations between clinical responses and radiographically demonstrated responses; both should be assessed on a regular basis. It is recommended that ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.

A user-friendly ePRO monitoring system can reduce patient uncertainty regarding disease management and promote patient-centered cardiovascular care.” 1 1. Yamashita S, Katsumata Y, Kohsaka S, et al.

The PST-611-CT1 Phase I trial ... clinical studies with our lead program PST-611. PST-611 has shown unique features in terms of efficacy, safety and durability of effect in a robust preclinical plan.

Trinity Biotech plc has announced encouraging results from its recent pre-pivotal clinical trial of its next-generation continuous glucose monitoring (CGM) system, targeting diabetes management.